Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Disavowal of Claim Scope and Beauregard Method Claims

Thanks Ron,

We settled the J3 at the entrance to the court room. The same quarter we licensed 10, maybe 11 other companies. On top of a favorable Markman. That was the single biggest quarter I can recall in our history, of licenses issued. Our revenue (PTSC) that quarter was in the area of $12MM. Legal expenses came in over $9MM. What were Alliacense and TPL doing ? Giving discounted licenses because we were being re-examined ? Is that going to change now, since we are not being re-examined ?

You might be right. Further patent challenges might not be considered by Patent and Trade Office. I think that's speculative, and harmful thinking. I'm not confident that another challenge can't be granted, though. With 300, or more, companies on notice of infringement, I wouldn't be surprised if another patent challenge came up. If one (or a group) of those infringers does drop a bomb on us, before we've established any momentum in licensing with escalating fees, I believe we will be bag holders.

Perceptive Reality just keeps rolling over like a well trained dog.

What's a little more time ?

I can at least hold off the negativity till after the new Markman and the outcome of the Barco case. They are seperate proceedings from Acer and HTC ? Right ?

Share
New Message
Please login to post a reply